Third International Summit on Human Genome Editing
07-03-2022 t/m 09-03-2022 The Francis Crick Institute, London, UK
Building on previous events held in Washington, D.C. (2015) and Hong Kong (2018), this Summit will continue the important dialogue around human genome editing. It will facilitate a global discussion on somatic and germline genome editing, including developments in clinical trials and genome editing tools such as CRISPR/Cas9. It will also address the recent report from the International Commission on the Clinical use of Heritable Human Genome Editing and the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing report.
Looking Ahead to the Third Human Genome Editing Summit online events 7-9 March
These events, which run from 7-9 March 2022, have been designed to explore some of the priority topics of the Third International Summit on Human Genome Editing, which had to be postponed and will now be held 6-8 March 2023. Brief descriptions are included below and further details of speakers available here.
All three events will be live streamed and will be available to watch afterwards, and there is no need to register. The sessions will consist of live and recorded presentations, followed by panel discussions with questions from the audience. Access to the livestreams and recorded presentations will be available via the Royal Society event page.
The events have been organised by the UK Royal Society in partnership with the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences.
Event timings and description:
- 7 March 13:40 - 16:00 UK GMT: Looking Ahead to the Science
Will include discussions on the state of the science and recent developments in somatic editing, particularly delivery mechanisms for genome editing in vivo, and germline editing, particularly developments in producing edited gametes.
- 8 March 14:00 - 16:00 UK GMT: Looking Ahead to the Equity & Access
The first half of this session will focus on health system barriers to access new somatic genome editing technologies, particularly in low- and middle- income countries. This will be followed by presentations on different ways to address price as a barrier to access in higher-income countries, both within the current research and development framework and beyond.
- 9 March 14:00 - 17:00 UK GMT: Looking Ahead to the Governance
Presentations will include research on current regulatory frameworks and challenges for governance of somatic and heritable editing – if heritable genome editing is deemed safe and acceptable. The session will also focus on the governance recommendations from the International Commission on the Clinical use of Heritable Human Genome Editing and the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing reports, and how these could be operationalised within nations and internationally.
See the event page for the full agenda and speaker line up, and to access the livestreams when available.